Georgi Marinov serves as the Clinical Science Director for Hematology/Oncology at PPD, where he leverages his extensive background in the biomedical field to drive innovative clinical research initiatives. With a career that spans both academia and the pharmaceutical industry, Georgi brings a wealth of knowledge...
Georgi Marinov serves as the Clinical Science Director for Hematology/Oncology at PPD, where he leverages his extensive background in the biomedical field to drive innovative clinical research initiatives. With a career that spans both academia and the pharmaceutical industry, Georgi brings a wealth of knowledge in molecular biology, biotechnology, and biochemistry to his role. He is instrumental in leading and developing comprehensive scientific strategies for full product development, ensuring that all program-level activities align with the highest standards of Good Clinical Practice (GCP).
At PPD, Georgi's expertise is pivotal in delivering key client outcomes, including gap analysis, Target Product Profile (TPP) generation, and the design and writing of clinical development plans (CDPs). His meticulous approach to protocol development and review not only enhances the quality of clinical trials but also ensures that they meet regulatory requirements and address the specific needs of patients with hematological malignancies and solid tumors.
Georgi's commitment to advancing the field of hematology and oncology is evident in his collaborative efforts with cross-functional teams, where he provides critical insights that shape clinical trial designs and methodologies. His proficiency in pharmacovigilance further underscores his dedication to patient safety and the integrity of clinical research. As he continues to navigate the dynamic landscape of clinical science, Georgi remains focused on fostering innovation and improving therapeutic outcomes for patients battling cancer.
